Listed biotechnology firm听e-therapeutics听has replaced听颁贰翱听Ali Mortazavi as听chair听as it splits the roles.听
Former long-time CEO of Silence Therapeutics and former professional chess player Mortazavi joined the Newcastle University spin-out as executive chairman in February 2020听and was appointed CEO in October.听听
Mortazavi听oversaw a听raise听of听拢11.6听million听growth funding to expand its platform capabilities,听asset pipeline, team and relocate its听head office听in听Oxford听鈥� where it is now based听鈥撎�and听open a new London base.听听
He is credited with a reorganisation of听e-therapeutics, which last year听expanded into RNA interference as a therapeutic modality to pursue drug discovery outcomes.听
Now听Professor Trevor Jones, an听independent听non-executive听director of the Company since 2015, will assume the role of听non-executive听chairman, allowing听Mortazavi听to focus on his CEO role.听
Jones听has held significant roles including听director of Allergan Inc. from 2005 to 2015 and R&D听director of The听Wellcome听Foundation from 1987 to 1994, where he was responsible for the development of AZT, Zovirax, Lamictal and听Malarone.听听
He is听visiting听professor at King’s College, London and holds honorary degrees and听gold听medals from seven universities.听
/7m-funding-to-commercialise-cambridge-uni-battery-tech/
The听company听said it听continues to search for an additional听non-executive听director to strengthen听its board.听
“I am delighted with my appointment. e-therapeutics has a world-class team of scientists who are discovering entirely novel therapeutics using their unique approach to network pharmacology,鈥� said Jones.听听
鈥�The appointment last year of Ali Mortazavi has led to a step-change in the听company’s performance and we are in a strong position to continue our successful internal programmes and partnerships with major pharmaceutical and biotech companies.”听
Mortazavi听added:听“I am very pleased that Trevor has agreed to become the听non-executive听chairman of e-therapeutics.听听
鈥�Having served as a听non-executive听director for many years, Trevor has an in-depth knowledge of the Company and I am very much looking forward to working more closely with him.听
“Trevor has had a distinguished career at the helm of leading pharmaceutical and governmental organisations during which he has made major contributions to human health and to business.听听
鈥�His breadth of experience in all aspects of the biopharma industry will be invaluable to us as we strive to achieve our long-term ambitions in drug development.”听
/feature-submissions/